The Pirbright Institute holds a collection of over 500 hybridomas that produce monoclonal antibodies (mAbs) against cattle, pig and chicken cell surface markers or viral proteins. Pirbright has recently started a major collaborative project to sequence all of these hybridomas into transfectable gene blocks that could be used in the future antibody engineering.
